Page last updated: 2024-11-01

5-nitro-2-(3-phenylpropylamino)benzoic acid and Laryngeal Neoplasms

5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Laryngeal Neoplasms in 1 studies

5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist

Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yu, WF1
Zhao, YL1
Wang, K1
Dong, MM1

Other Studies

1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Laryngeal Neoplasms

ArticleYear
Inhibition of cell proliferation and arrest of cell cycle progression by blocking chloride channels in human laryngeal cancer cell line Hep-2.
    Neoplasma, 2009, Volume: 56, Issue:3

    Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chloride Channels; Dose-Response Relationship, Dru

2009